IRMD (iRadimed Corporation) Stock Analysis - Analyst Ratings

iRadimed Corporation (IRMD) is a publicly traded Healthcare sector company. As of May 21, 2026, IRMD trades at $90.40 with a market cap of $1.13B and a P/E ratio of 47.84. IRMD moved +1.82% today. Year to date, IRMD is -8.04%; over the trailing twelve months it is +69.64%. Its 52-week range spans $46.86 to $107.90. Analyst consensus is buy with an average price target of $116.00. Rallies surfaces IRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate IRMD?

1 analysts cover IRMD: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $116.00.

IRMD Key Metrics

Key financial metrics for IRMD
MetricValue
Price$90.40
Market Cap$1.13B
P/E Ratio47.84
EPS$1.86
Dividend Yield0.20%
52-Week High$107.90
52-Week Low$46.86
Volume0
Avg Volume0
Revenue (TTM)$86.28M
Net Income$23.61M
Gross Margin76.83%

IRMD Analyst Consensus

1 analysts cover IRMD: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $116.00.

Latest IRMD News

Recent IRMD Insider Trades

  • Susi Roger E. sold 653 (~$56.90K) on May 19, 2026.
  • Susi Roger E. sold 1.84K (~$162.27K) on May 19, 2026.
  • Susi Roger E. sold 6 (~$531.9) on May 19, 2026.

Common questions about IRMD

What do analysts rate IRMD?
1 analysts cover IRMD: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $116.00.
Does Rallies show IRMD price targets?
Yes. Rallies tracks IRMD analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is IRMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IRMD. It does not provide personalized investment advice.
IRMD

IRMD